CAR-T Cell Therapy in RelApsed/Refractory Myeloma With ExtrameduLlary Disease - an in Vivo Imaging and Molecular Monitoring Study
Clinical trial NCT05666700 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05666700
- Sponsor
- Peter MacCallum Cancer Centre, Australia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-08
- Primary completion
- 2027-01-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.